)
)
Ultragenyx Pharmaceutical Investor Relations Material
Latest events
Q3 2024
Ultragenyx Pharmaceutical
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Ultragenyx Pharmaceutical Inc
Access all reports
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies for rare and ultra-rare genetic diseases. The company's focus includes treatments for metabolic disorders, bone diseases, and other conditions with significant unmet medical needs. Ultragenyx leverages innovative research and targeted approaches to address complex diseases that often lack effective therapies.The company is headquartered in Novato, California, and its shares are listed on the NASDAQ.
Key slides for Ultragenyx Pharmaceutical Inc
Q2 2024
Ultragenyx Pharmaceutical Inc
Q2 2024
Ultragenyx Pharmaceutical Inc
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
RARE
Country
🇺🇸 United States